Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SK Clinical Oy
OY
Active
Y-tunnus 3373181-1
Rosendalinrinki 3A-36, 01520
Vantaa
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023
— employees
Watchlist
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SK Clinical Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
EUR thousands
Item
2024
2025
Revenue
75
101
Staff expenses
42
−77
EBITDA
137
11
Depreciation & amort.
—
—
EBIT
13
11
Net financials
—
—
Profit before tax
13
11
Tax
3
−2
Net profit
11
9
Balance sheet
EUR thousands
Item
2024
2025
Total assets
25
37
Equity
22
29
Long-term debt
—
—
Short-term debt
3
8
Total debt
3
8
Financial ratios
5-year trend
EBITDA margin
10.8%
This company
15.8%
Market median
-32% vs market
2024
2025
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
2024
2025
Return on equity
30.3%
This company
18.4%
Market median
+65% vs market
2024
2025
Net profit margin
8.7%
This company
8.1%
Market median
+7% vs market
2024
2025
Asset turnover
2.77×
This company
1.12×
Market median
+147% vs market
2024
2025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
More on SK Clinical Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
